Back
Nektar Therapeutics Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
NKTR
Nektar Therapeutics
Last Price:
1.02
Seasonality Move:
15.74%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Nektar Therapeutics Stock Forecast
-
Is Nektar Therapeutics Stock Undervalued?
The current Nektar Therapeutics [NKTR] share price is $1.00. The Score for NKTR is 30, which is 40% below its historic median score of 50, and infers higher risk than normal. - NKTR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Nektar Therapeutics Stock Go Up Next Year?
Data Unavailable
Nektar Therapeutics Stock Rating
Data Unavailable
Nektar Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
nektar.com
52-Week Data
52-Week High:
1.93
52-Week Low:
0.42
Prediction Charts
Market Cap:
184.46M
Price in USD:
1.00
Volume:
1.49M
Beta:
1.15
Technical Analysis
SMA50:
1.28
SMA100:
1.28
SMA200:
1.23
52-Wk Change:
92.31%
Stock Predictions
-
Is Nektar Therapeutics stock public?
Yes, Nektar Therapeutics is a publicly traded company. -
What is the Nektar Therapeutics stock quote today?
The Nektar Therapeutics stock price is 1.00 USD today. -
How to buy Nektar Therapeutics stock online?
You can buy Nektar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-1 | 1.21 | 1.23 | 1.27 | 1.21 |
| Nov-4 | 1.37 | 1.34 | 1.47 | 1.27 |
| Nov-5 | 1.34 | 1.40 | 1.41 | 1.34 |
| Nov-6 | 1.43 | 1.39 | 1.47 | 1.36 |
| Nov-7 | 1.41 | 1.37 | 1.42 | 1.33 |
| Nov-8 | 1.38 | 1.40 | 1.43 | 1.36 |
| Nov-11 | 1.40 | 1.37 | 1.42 | 1.36 |
| Nov-12 | 1.37 | 1.32 | 1.38 | 1.30 |
| Nov-13 | 1.33 | 1.29 | 1.37 | 1.28 |
| Nov-14 | 1.29 | 1.17 | 1.30 | 1.16 |
| Nov-15 | 1.20 | 1.07 | 1.20 | 1.04 |
| Nov-18 | 1.07 | 1.03 | 1.09 | 1.02 |
| Nov-19 | 1.02 | 1.03 | 1.04 | 1.00 |
| Nov-20 | 1.07 | 1.00 | 1.07 | 1.00 |
Nektar Therapeutics Earnings
Data Unavailable
Nektar Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and a decrease next year of $0.08 per share.
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.